Loading company…
Solstice Oncology develops pre-surgical cancer therapies for colon cancer and other early-stage solid tumors.
Founded in 2026 and based in Massachusetts, Solstice Oncology is a clinical-stage immuno-oncology company. It develops therapies for use before surgery to target colon cancer and other early-stage solid tumors.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in